DOI:
10.1055/s-00000105
Zentralblatt für Gynäkologie
LinksClose Window
References
Mackay JR, Paterson A, Dirix L. et al.
Final results of the phase III randomized trial comparing docetaxel (T), doxorubicin (A) and cyclophosphamide (C) to FAC as first line chemotherapy (CT) for patients (pts) with metastatic breast cancer (MBC) (abstr).
Proc Am Soc Clin Oncol 2002; 21: 137-137
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.